Royalty Pharma | 4:持股变动声明-高管 Hite Christopher
Royalty Pharma | 4:持股变动声明-董事 Fernandez Henry A
Royalty Pharma | 4:持股变动声明-董事 Bassler Bonnie L
Royalty Pharma | 4:持股变动声明-董事 RIGGS RORY B
Royalty Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(8.54%)
Royalty Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-General Atlantic, L.P.(5.6%),GAP Coinvestments CDA, L.P.(5.6%)等
Royalty Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-Morgan Stanley(9.2%),Morgan Stanley Investment Management Inc.(8.9%)
Royalty Pharma | SC 13G/A:超过5%持股股东披露文件(修正)-FMR LLC(7.099%),Abigail P. Johnson(7.099%)
Royalty Pharma | 4:持股变动声明-董事 RIGGS RORY B
Royalty Pharma | 4:持股变动声明-股东 Avara Management Ltd
Royalty Pharma | 4:持股变动声明-董事 Fernandez Henry A
Royalty Pharma | 4:持股变动声明-董事 Bassler Bonnie L
Royalty Pharma | 4:持股变动声明-股东 Avara Management Ltd
Royalty Pharma | 4:持股变动声明-股东 Avara Management Ltd
Royalty Pharma | 4:持股变动声明-股东 Avara Management Ltd
Royalty Pharma | 4:持股变动声明-高管 Legorreta Pablo G.
Royalty Pharma | 4:持股变动声明-高管 Lloyd George W.
Royalty Pharma | 4:持股变动声明-董事 RIGGS RORY B
Royalty Pharma | 4:持股变动声明-董事 Fernandez Henry A
Royalty Pharma | 4:持股变动声明-董事 Bassler Bonnie L
暂无数据